[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Editor's Correspondence
September 22, 2003

Prevalence of Isolated Advanced Proximal Neoplasia

Author Affiliations

Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003

Arch Intern Med. 2003;163(17):2103. doi:10.1001/archinte.163.17.2103-a

Lewis et al,1 in their meta-analysis, report a prevalence of isolated advanced proximal neoplasia ranging from 2% to 5%, with a pooled estimate of 2.4%. However, the prevalence rates from the individual studies were calculated by including only subjects who had negative flexible sigmoidoscopy findings. This calculation is biased, since it does not reflect when a patient is counseled regarding the differences between flexible sigmoidoscopy and colonoscopy in the decision-making process. The appropriate time for a patient to be counseled about the yields of the 2 tests is prior to the initiation of either test. Thus, the correct prevalence is the prevalence of isolated advanced proximal neoplasia in all subjects presenting for screening. Using that denominator, the prevalence of isolated advanced proximal neoplasia in the screening colonoscopy studies is 1.2%2 and 2.1%, respectively,3 not 2% and 3% as reported in Figure 4 B. By including only subjects with negative sigmoidoscopy findings, Lewis et al1 have overestimated the prevalence of isolated advanced proximal neoplasia. If a practitioner is going to attempt to influence the patient to have a full colonoscopy after a negative flexible sigmoidoscopy, then there is no point in performing the sigmoidoscopy.